Markets › LSE › OXB.L

Oxford Biomedica plc

LSE:OXB.LHealthcareFTSE:ASXFTSE:MCX

£5.21+1.96%At closeAt close · Tue 20 Oct · ≈ AED 25.47 · Market cap $823.34M · Next earnings Thu 15 Apr

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	52.5%	57.9%	49.4%	44.4%	41.2%	39.1%	—	—
Operating margin	−6.5%	14.5%	−21.6%	−205.7%	−30.6%	−17.5%	−17.5%	+0.0 pts
Net margin	−7.1%	13.3%	−28.0%	−175.9%	−33.5%	−17.9%	−17.9%	+0.0 pts
EBITDA margin	4.5%	23.3%	−7.7%	−166.0%	−11.1%	−5.4%	—	—
Return on equity	−5.5%	10.1%	−19.1%	−212.8%	−75.7%	−33.0%	−33.0%	+0.0 pts
Return on assets	−3.4%	8.0%	−8.5%	−62.4%	−18.6%	−9.2%	−9.2%	+0.0 pts
Return on capital employed	−4.3%	10.2%	−7.5%	−88.5%	−22.7%	−12.3%	—	—
Debt / equity	0.1×	0.0×	0.6×	1.5×	1.9×	1.6×	1.6×	+0.0%
Debt / assets	7.5%	3.9%	24.8%	44.2%	47.0%	45.5%	—	—
Interest coverage	−6.2×	23.4×	−3.5×	−16.4×	−4.0×	−2.1×	—	—
Current ratio	2.1×	4.9×	3.6×	3.2×	2.3×	2.2×	2.2×	+0.0%
Quick ratio	1.9×	4.6×	3.4×	2.9×	2.1×	2.0×	—	—
Cash ratio	0.9×	3.3×	2.4×	2.3×	1.0×	1.2×	1.2×	+0.0%
Asset turnover	0.5×	0.6×	0.3×	0.4×	0.6×	0.5×	—	—
Inventory turnover	6.0×	6.3×	5.6×	3.9×	5.6×	5.9×	—	—
Receivables turnover	1.7×	3.4×	2.4×	6.7×	3.1×	2.6×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—